SCHEMBL21391262

SCHEMBL21391262

CCN1CCC2(CC1)CN(C(=O)c1ccccc1)C[C@@H](C)O2

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.49
CHRM3 P20309 2/20 0.49
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ACHE P22303 1/20 0.43
OPRM1 P35372 6/20 0.43
SIGMAR1 Q99720 5/20 0.43
KCNH2 Q12809 2/20 0.43
BLM P54132 1/20 0.42
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 1/20 0.41
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
PLA2G1B P04054 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17318776 0.89 CHRM2 (0.61) CHRM2CHRM3ALDH1A1KMT2AKDM4E
Hydrochloric Acid SCHEMBL17318786 0.88 CHRM2 (0.60) CHRM2CHRM3ALDH1A1KMT2AKDM4E
SCHEMBL19096873 0.87 HPGD (0.50) CHRM2CHRM3ALDH1A1HPGDKMT2A
SCHEMBL20058423 0.87 ALDH1A1 (0.50) CHRM2CHRM3ALDH1A1HPGDKMT2A
SCHEMBL17318795 0.87 CHRM2 (0.46) CHRM2CHRM3ALDH1A1HPGDKMT2A
SCHEMBL17318994 0.87 SIGMAR1 (0.57) KMT2AOPRM1SIGMAR1KCNH2MEN1
Hydrochloric Acid SCHEMBL19096857 0.86 CHRM2 (0.45) CHRM2CHRM3ALDH1A1HPGDKMT2A
Hydrochloric Acid SCHEMBL17318878 0.86 SIGMAR1 (0.56) KMT2AOPRM1SIGMAR1KCNH2MEN1
SCHEMBL17328294 0.85 SIGMAR1 (0.54) CHRM2CHRM3KMT2AOPRM1SIGMAR1
SCHEMBL17328271 0.85 CHRM2 (0.45) CHRM2CHRM3ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019180188-A1 AMINOPROPOXYPHENYL AND BENZYL 1-OXA-4,9-DIAZASPIROUNDECANE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2019-09-26 WO disclosed